(-)-alpha-phellandrene increases expression ISO RGD:1346352 6480464 alpha phellandrene results in increased expression of CDKN2D mRNA CTD PMID:25075043 1,2-dichloroethane decreases expression ISO RGD:1617633 6480464 ethylene dichloride results in decreased expression of CDKN2D mRNA CTD PMID:28960355 1,2-dimethylhydrazine multiple interactions EXP 6480464 [APC protein affects the susceptibility to 1, 2-Dimethylhydrazine] which results in decreased expression of CDKN2D mRNA CTD PMID:27840820 1,3-dinitrobenzene increases expression EXP 6480464 3-dinitrobenzene results in increased expression of CDKN2D mRNA CTD PMID:21983209 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine increases expression ISO RGD:1617633 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:15329391 17beta-estradiol decreases expression ISO RGD:1346352 6480464 Estradiol results in decreased expression of CDKN2D mRNA CTD PMID:23019147 , PMID:23094148 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1346352 6480464 2 more ... CTD PMID:26988655 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1617633 6480464 Tetrachlorodibenzodioxin affects the expression of CDKN2D mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1617633 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CDKN2D promoter] CTD PMID:19654925 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1617633 6480464 Tetrachlorodibenzodioxin results in increased expression of CDKN2D mRNA CTD PMID:15667827 , PMID:17337447 2-hydroxypropanoic acid affects expression ISO RGD:1346352 6480464 Lactic Acid affects the expression of CDKN2D mRNA CTD PMID:30851411 3,3'-diindolylmethane increases expression ISO RGD:1346352 6480464 3, 3'-diindolylmethane results in increased expression of CDKN2D protein CTD PMID:22290291 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1346352 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CDKN2D mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1617633 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of CDKN2D mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol increases expression ISO RGD:1346352 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of CDKN2D mRNA CTD PMID:36565802 4-hydroxynon-2-enal decreases expression ISO RGD:1346352 6480464 4-hydroxy-2-nonenal results in decreased expression of CDKN2D mRNA CTD PMID:12419474 4-hydroxynon-2-enal decreases expression ISO RGD:1617633 6480464 4-hydroxy-2-nonenal results in decreased expression of CDKN2D mRNA CTD PMID:19191707 5-aza-2'-deoxycytidine increases expression ISO RGD:1346352 6480464 Decitabine results in increased expression of CDKN2D mRNA CTD PMID:16367923 , PMID:17785578 5-aza-2'-deoxycytidine increases expression ISO RGD:1617633 6480464 Decitabine results in increased expression of CDKN2D mRNA CTD PMID:27915011 all-trans-retinoic acid multiple interactions ISO RGD:1346352 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of CDKN2D mRNA CTD PMID:15894607 all-trans-retinoic acid multiple interactions ISO RGD:1617633 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of CDKN2D mRNA CTD PMID:30951980 all-trans-retinoic acid increases expression ISO RGD:1346352 6480464 Tretinoin results in increased expression of CDKN2D mRNA, Tretinoin results in increased expression of CDKN2D protein CTD PMID:15894607 , PMID:16322758 alpha-phellandrene increases expression ISO RGD:1346352 6480464 alpha phellandrene results in increased expression of CDKN2D mRNA CTD PMID:25075043 antirheumatic drug decreases expression ISO RGD:1346352 6480464 Antirheumatic Agents results in decreased expression of CDKN2D mRNA CTD PMID:24449571 aristolochic acid A increases expression ISO RGD:1346352 6480464 aristolochic acid I results in increased expression of CDKN2D mRNA CTD PMID:33212167 arsane increases expression ISO RGD:1346352 6480464 Arsenic results in increased expression of CDKN2D mRNA CTD PMID:11134558 arsenic atom increases expression ISO RGD:1346352 6480464 Arsenic results in increased expression of CDKN2D mRNA CTD PMID:11134558 arsenous acid increases expression ISO RGD:1346352 6480464 Arsenic Trioxide results in increased expression of CDKN2D mRNA CTD PMID:19769630 , PMID:20458559 arsenous acid multiple interactions ISO RGD:1346352 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of CDKN2D mRNA CTD PMID:15894607 avobenzone increases expression ISO RGD:1346352 6480464 avobenzone results in increased expression of CDKN2D mRNA CTD PMID:31016361 benzo[a]pyrene multiple interactions ISO RGD:1617633 6480464 Benzo(a)pyrene promotes the reaction [AHR protein binds to CDKN2D promoter] CTD PMID:19654925 bisphenol A multiple interactions ISO RGD:1346352 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CDKN2D mRNA CTD PMID:28628672 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CDKN2D mRNA CTD PMID:34947998 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CDKN2D mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:1617633 6480464 bisphenol A results in increased expression of CDKN2D mRNA CTD PMID:26063408 bisphenol A increases expression ISO RGD:1346352 6480464 bisphenol A results in increased expression of CDKN2D mRNA CTD PMID:25047013 cadmium dichloride increases expression ISO RGD:1346352 6480464 Cadmium Chloride results in increased expression of CDKN2D mRNA CTD PMID:32512071 calciol increases expression ISO RGD:1346352 6480464 Cholecalciferol results in increased expression of CDKN2D CTD PMID:16582618 calcitriol multiple interactions ISO RGD:1346352 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of CDKN2D mRNA CTD PMID:21592394 calcitriol increases expression ISO RGD:1346352 6480464 Calcitriol results in increased expression of CDKN2D mRNA, Calcitriol results in increased expression of CDKN2D protein CTD PMID:16322758 calcitriol decreases expression ISO RGD:1346352 6480464 Calcitriol results in decreased expression of CDKN2D mRNA CTD PMID:21592394 calycosin decreases expression ISO RGD:1346352 6480464 7, 3'-dihydroxy-4'-methoxyisoflavone results in decreased expression of CDKN2D mRNA CTD PMID:24455688 CGP 52608 multiple interactions ISO RGD:1346352 6480464 CGP 52608 promotes the reaction [RORA protein binds to CDKN2D gene] CTD PMID:28238834 chromium(6+) increases expression ISO RGD:1346352 6480464 chromium hexavalent ion results in increased expression of CDKN2D mRNA CTD PMID:17382205 cisplatin increases expression ISO RGD:1346352 6480464 Cisplatin results in increased expression of CDKN2D mRNA CTD PMID:27594783 copper atom multiple interactions ISO RGD:1346352 6480464 [Chelating Agents binds to Copper] which results in increased expression of CDKN2D mRNA, [Chelating Agents binds to Copper] which results in increased expression of CDKN2D protein CTD PMID:30911355 copper(0) multiple interactions ISO RGD:1346352 6480464 [Chelating Agents binds to Copper] which results in increased expression of CDKN2D mRNA, [Chelating Agents binds to Copper] which results in increased expression of CDKN2D protein CTD PMID:30911355 copper(II) sulfate decreases expression ISO RGD:1346352 6480464 Copper Sulfate results in decreased expression of CDKN2D mRNA CTD PMID:19549813 cumene decreases expression ISO RGD:1617633 6480464 cumene results in decreased expression of CDKN2D mRNA CTD PMID:18648096 curcumin decreases expression EXP 6480464 Curcumin results in decreased expression of CDKN2D mRNA CTD PMID:18299980 cyclophosphamide decreases expression ISO RGD:1617633 6480464 Cyclophosphamide results in decreased expression of CDKN2D mRNA CTD PMID:21041162 cyclosporin A increases expression ISO RGD:1346352 6480464 Cyclosporine results in increased expression of CDKN2D mRNA CTD PMID:25562108 cypermethrin decreases expression EXP 6480464 cypermethrin results in decreased expression of CDKN2D mRNA CTD PMID:22528246 dexamethasone multiple interactions ISO RGD:1346352 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CDKN2D mRNA CTD PMID:28628672 dexamethasone decreases expression ISO RGD:1617633 6480464 Dexamethasone results in decreased expression of CDKN2D mRNA CTD PMID:21041162 diarsenic trioxide increases expression ISO RGD:1346352 6480464 Arsenic Trioxide results in increased expression of CDKN2D mRNA CTD PMID:19769630 , PMID:20458559 diarsenic trioxide multiple interactions ISO RGD:1346352 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of CDKN2D mRNA CTD PMID:15894607 dibutyl phthalate decreases expression ISO RGD:1617633 6480464 Dibutyl Phthalate results in decreased expression of CDKN2D mRNA CTD PMID:17361019 , PMID:21266533 diethylstilbestrol decreases expression ISO RGD:1617633 6480464 Diethylstilbestrol results in decreased expression of CDKN2D mRNA CTD PMID:21041162 dioxygen increases expression ISO RGD:1617633 6480464 Oxygen deficiency results in increased expression of CDKN2D mRNA CTD PMID:24205000 dorsomorphin multiple interactions ISO RGD:1346352 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDKN2D mRNA CTD PMID:27188386 formaldehyde increases expression ISO RGD:1346352 6480464 Formaldehyde results in increased expression of CDKN2D mRNA CTD PMID:23649840 hydrogen peroxide affects expression ISO RGD:1346352 6480464 Hydrogen Peroxide affects the expression of CDKN2D mRNA, Hydrogen Peroxide affects the expression of CDKN2D protein CTD PMID:20044591 , PMID:21179406 hydrogen peroxide decreases expression ISO RGD:1346352 6480464 Hydrogen Peroxide results in decreased expression of CDKN2D mRNA CTD PMID:12419474 indometacin multiple interactions ISO RGD:1346352 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CDKN2D mRNA CTD PMID:28628672 iron atom increases expression ISO RGD:1346352 6480464 Iron deficiency results in increased expression of CDKN2D mRNA CTD PMID:20368581 iron(0) increases expression ISO RGD:1346352 6480464 Iron deficiency results in increased expression of CDKN2D mRNA CTD PMID:20368581 lead(0) affects expression ISO RGD:1346352 6480464 Lead affects the expression of CDKN2D mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:1346352 6480464 Lead affects the expression of CDKN2D mRNA CTD PMID:28903495 levonorgestrel multiple interactions ISO RGD:1346352 6480464 [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CDKN2D mRNA CTD PMID:19074003 Licochalcone B increases expression ISO RGD:1346352 6480464 licochalcone B results in increased expression of CDKN2D mRNA CTD PMID:33647349 lipopolysaccharide increases expression ISO RGD:1617633 6480464 Lipopolysaccharides results in increased expression of CDKN2D mRNA CTD PMID:12057914 LY294002 multiple interactions ISO RGD:1346352 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of CDKN2D mRNA] CTD PMID:12710931 methyl methanesulfonate increases expression ISO RGD:1346352 6480464 Methyl Methanesulfonate results in increased expression of CDKN2D mRNA CTD PMID:23649840 methylseleninic acid affects expression ISO RGD:1346352 6480464 methylselenic acid affects the expression of CDKN2D mRNA CTD PMID:14617803 methylseleninic acid increases expression ISO RGD:1346352 6480464 methylselenic acid results in increased expression of CDKN2D mRNA CTD PMID:12517777 mono(2-ethylhexyl) phthalate multiple interactions ISO RGD:1617633 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of CDKN2D mRNA CTD PMID:31884101 monobenzyl phthalate multiple interactions ISO RGD:1617633 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of CDKN2D mRNA CTD PMID:31884101 monoethyl phthalate multiple interactions ISO RGD:1617633 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of CDKN2D mRNA CTD PMID:31884101 monosodium L-glutamate decreases expression EXP 6480464 Sodium Glutamate results in decreased expression of CDKN2D mRNA CTD PMID:28954212 N-methyl-4-phenylpyridinium multiple interactions ISO RGD:1346352 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of CDKN2D mRNA] CTD PMID:12710931 N-nitrosodiethylamine decreases expression ISO RGD:1617633 6480464 Diethylnitrosamine results in decreased expression of CDKN2D mRNA CTD PMID:18282651 N-nitrosodiethylamine multiple interactions ISO RGD:1617633 6480464 RB1 protein promotes the reaction [Diethylnitrosamine results in decreased expression of CDKN2D mRNA] CTD PMID:18282651 nickel sulfate increases expression ISO RGD:1346352 6480464 nickel sulfate results in increased expression of CDKN2D mRNA CTD PMID:17382205 p-menthan-3-ol decreases expression ISO RGD:1346352 6480464 Menthol results in decreased expression of CDKN2D mRNA CTD PMID:26760959 paracetamol increases expression ISO RGD:1346352 6480464 Acetaminophen results in increased expression of CDKN2D mRNA CTD PMID:21420995 , PMID:29067470 perfluorohexanesulfonic acid increases expression ISO RGD:1346352 6480464 perfluorohexanesulfonic acid results in increased expression of CDKN2D mRNA CTD PMID:25812627 perfluorononanoic acid increases expression ISO RGD:1346352 6480464 perfluoro-n-nonanoic acid results in increased expression of CDKN2D mRNA CTD PMID:25812627 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1617633 6480464 [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of CDKN2D mRNA CTD PMID:36331819 phenobarbital affects expression ISO RGD:1617633 6480464 Phenobarbital affects the expression of CDKN2D mRNA CTD PMID:23091169 phenylmercury acetate multiple interactions ISO RGD:1346352 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDKN2D mRNA CTD PMID:27188386 phenylmercury acetate increases expression ISO RGD:1346352 6480464 Phenylmercuric Acetate results in increased expression of CDKN2D mRNA CTD PMID:26272509 potassium chromate increases expression ISO RGD:1346352 6480464 potassium chromate(VI) results in increased expression of CDKN2D mRNA CTD PMID:17382205 potassium dichromate increases expression ISO RGD:1346352 6480464 Potassium Dichromate results in increased expression of CDKN2D mRNA CTD PMID:11678601 pyrazinecarboxamide increases expression EXP 6480464 Pyrazinamide results in increased expression of CDKN2D mRNA CTD PMID:22431067 rac-lactic acid affects expression ISO RGD:1346352 6480464 Lactic Acid affects the expression of CDKN2D mRNA CTD PMID:30851411 reactive oxygen species increases expression ISO RGD:1346352 6480464 Reactive Oxygen Species results in increased expression of CDKN2D mRNA CTD PMID:25800948 rotenone increases expression ISO RGD:1617633 6480464 Rotenone results in increased expression of CDKN2D mRNA CTD PMID:32937126 SB 431542 multiple interactions ISO RGD:1346352 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDKN2D mRNA CTD PMID:27188386 silver atom decreases expression ISO RGD:1617633 6480464 Silver results in decreased expression of CDKN2D mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1617633 6480464 Silver results in decreased expression of CDKN2D mRNA CTD PMID:27131904 simvastatin increases expression ISO RGD:1346352 6480464 Simvastatin results in increased expression of CDKN2D mRNA, Simvastatin results in increased expression of CDKN2D protein CTD PMID:20878096 sodium arsenite increases expression ISO RGD:1346352 6480464 sodium arsenite results in increased expression of CDKN2D mRNA CTD PMID:28595984 sunitinib decreases expression ISO RGD:1346352 6480464 Sunitinib results in decreased expression of CDKN2D mRNA CTD PMID:31533062 testosterone multiple interactions ISO RGD:1346352 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of CDKN2D mRNA CTD PMID:21592394 testosterone decreases expression ISO RGD:1346352 6480464 Testosterone results in decreased expression of CDKN2D mRNA CTD PMID:21592394 testosterone undecanoate multiple interactions ISO RGD:1346352 6480464 [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CDKN2D mRNA CTD PMID:19074003 tetrachloromethane increases expression ISO RGD:1617633 6480464 Carbon Tetrachloride results in increased expression of CDKN2D mRNA CTD PMID:31919559 trichloroethene increases expression ISO RGD:1617633 6480464 Trichloroethylene results in increased expression of CDKN2D mRNA CTD PMID:15363585 triptonide increases expression ISO RGD:1617633 6480464 triptonide results in increased expression of CDKN2D mRNA CTD PMID:33045310 trovafloxacin decreases expression ISO RGD:1617633 6480464 trovafloxacin results in decreased expression of CDKN2D mRNA CTD PMID:35537566 tungsten increases expression ISO RGD:1617633 6480464 Tungsten results in increased expression of CDKN2D mRNA CTD PMID:30912803 urethane increases expression ISO RGD:1346352 6480464 Urethane results in increased expression of CDKN2D mRNA CTD PMID:28818685 valproic acid increases expression ISO RGD:1346352 6480464 Valproic Acid results in increased expression of CDKN2D mRNA, Valproic Acid results in increased expression of CDKN2D protein CTD PMID:22083351 vancomycin decreases expression ISO RGD:1617633 6480464 Vancomycin results in decreased expression of CDKN2D mRNA CTD PMID:18930951 vorinostat increases expression ISO RGD:1346352 6480464 Vorinostat results in increased expression of CDKN2D mRNA, Vorinostat results in increased expression of CDKN2D protein CTD PMID:22083351